Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2026)

Autolus Therapeutics (AUTL) has 7 years of Other Operating Expenses data on file, last reported at $25.3 million in Q4 2025.

• Quarterly Other Operating Expenses changed N/A year-over-year to $25.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.3 million (up 11456.05% YoY) and the FY2025 annual result came in at $96.4 million, up 43314.8% from the prior year.
• Other Operating Expenses grew to $25.3 million in Q4 2025, from -$3000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $25.3 million in Q4 2025 to a low of -$3.8 million in Q1 2023.
• A 4-year average of $3.5 million and a median of -$123000.0 in 2023 frame the typical range for Other Operating Expenses.